KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Receivables - Net: 2009-2024

Historic Receivables - Net for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $171.2 million.

  • Chemed's Receivables - Net rose 971.54% to $215.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $215.6 million, marking a year-over-year increase of 971.54%. This contributed to the annual value of $171.2 million for FY2024, which is 570.1% down from last year.
  • Chemed's Receivables - Net amounted to $171.2 million in FY2024, which was down 570.1% from $181.5 million recorded in FY2023.
  • In the past 5 years, Chemed's Receivables - Net ranged from a high of $181.5 million in FY2023 and a low of $126.9 million during FY2020
  • Its 5-year average for Receivables - Net is $151.2 million, with a median of $139.4 million in 2022.
  • In the last 5 years, Chemed's Receivables - Net crashed by 1180.17% in 2020 and then soared by 3020.13% in 2023.
  • Chemed's Receivables - Net (Annual) stood at $126.9 million in 2020, then rose by 8.17% to $137.2 million in 2021, then grew by 1.6% to $139.4 million in 2022, then skyrocketed by 30.2% to $181.5 million in 2023, then dropped by 5.7% to $171.2 million in 2024.
  • Its Receivables - Net stands at $171.2 million for FY2024, versus $181.5 million for FY2023 and $139.4 million for FY2022.